Spero Therapeutics Inc. (SPRO) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Spero Therapeutics Inc.

    NASDAQ: SPRO · Real-Time Price · USD
    1.89
    -0.05 (-2.58%)
    At close: Sep 26, 2025, 3:59 PM
    1.89
    0.00%
    After-hours: Sep 26, 2025, 07:50 PM EDT

    Spero Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -0.81 3.40 -1.4 -5.51
    PEG Ratio
    		 0.00 -0.03 0.02 0.32
    PS Ratio
    		 2.03 0.80 1.34 27.09
    PB Ratio
    		 1.21 0.72 0.86 5.60
    P/FCF Ratio
    		 -2.37 -2.35 -8.41 -7.69
    P/OCF Ratio
    		 -2.37 -2.35 -8.41 -7.69
    OCF/S Ratio
    		 -0.86 -0.34 -0.16 -3.52
    Debt / Equity Ratio
    		 0.09 0.05 0.09 0.63
    Quick Ratio
    		 2.19 3.53 5.25 8.46
    Current Ratio
    		 2.19 3.53 5.04 8.46
    Asset Turnover
    		 0.25 0.53 0.39 0.11
    Interest Coverage
    		 n/a n/a -16.2 -45.35
    Return on Equity
    		 -1.49 0.21 -0.61 -1.02
    Return on Assets
    		 -0.62 0.13 -0.37 -0.52
    Return on Invested Capital
    		 -1.16 0.13 -0.41 -0.58
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 1.00 1.00 0.12 0.94
    Net Profit Margin
    		 -2.5 0.24 -0.96 -4.92
    Pretax Profit Margin
    		 -2.5 0.26 -0.96 -4.92
    Operating Profit Margin
    		 -2.68 0.22 -0.87 -4.82
    FCF Margin
    		 -0.86 -0.34 -0.16 -3.52
    EBITDA Margin
    		 -2.65 0.27 -0.87 -4.77

    Add to Watchlist